Clinical outcomes of Ex Vivo liver resection and liver autotransplantation for hepatic alveolar echinococcosis

Hai Wang , Qiaoyu Liu , Zhaoming Wang , Feng Zhang , Xiangcheng Li , Xuehao Wang

Current Medical Science ›› 2012, Vol. 32 ›› Issue (4) : 598 -600.

PDF
Current Medical Science ›› 2012, Vol. 32 ›› Issue (4) : 598 -600. DOI: 10.1007/s11596-012-1003-9
Article

Clinical outcomes of Ex Vivo liver resection and liver autotransplantation for hepatic alveolar echinococcosis

Author information +
History +
PDF

Abstract

The effectiveness of liver autotransplantation for patients with partial hepatic alveolar echinococcosis was analyzed. We retrospectively studied 6 patients with hepatic alveolar echinococcosis who underwent liver autotransplantation in our hospital from 2008 to 2010. We also summarized the surgical indications of liver autotransplantation for hepatic alveolar echinococcosis and our experience in the management of postoperative complications of liver autotransplantation. Of 6 patients, 5 achieved good curative results, and one died of multiple organ failure caused by portal vein thrombosis. Main complications included postoperative bleeding, bile leak and small-for-size liver graft syndrome. Liver autotransplantation offers a new approach to cure hepatic alveolar echinococcosis with non-resectable lesions. It could be the most effective method to cure intractable hepatic alveolar echinococcosis if correct handling in operation and proper prevention of complications are performed. But the long-term outcomes are still needed to be confirmed in longer follow-up.

Keywords

liver autotransplantation / hepatic alveolar echinococcosis / perioperative therapeutics / ex vivo

Cite this article

Download citation ▾
Hai Wang, Qiaoyu Liu, Zhaoming Wang, Feng Zhang, Xiangcheng Li, Xuehao Wang. Clinical outcomes of Ex Vivo liver resection and liver autotransplantation for hepatic alveolar echinococcosis. Current Medical Science, 2012, 32(4): 598-600 DOI:10.1007/s11596-012-1003-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

KadryZ., RennerE.C., BachmannL.M., et al.. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg, 2005, 92(9): 1110-1116

[2]

LiF., YangM., LiB., et al.. Initial clinical results of orthotopic liver transplantation for hepatic alveolar echinococcosis. Liver Transpl, 2007, 13(6): 924-926

[3]

GruttadauriaS., MarshJ.W., BartlettD. E. s., et al.. resection techniques and liver autotransplantation: last resource for otherwise unresectable malignancy. Dig Dis Sci, 2005, 50(10): 1829-1835

[4]

KochS., Bresson-HadniS., MiguetJ.P., et al.. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation, 2003, 75(6): 856-863

[5]

Bresson-HadniS., MiguetJ.P., LenysD., et al.. Recurrence of alveolar echinococcosis in the liver graft after liver transplantation. Hepatology, 1992, 16(1): 279-280

[6]

Bresson-HadniS., BlagosklonovO., KnappJ., et al.. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl, 2011, 17(7): 855-865

AI Summary AI Mindmap
PDF

97

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/